Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period.
The Food and Drug Administration (FDA) is reopening the comment period for the proposed rule concerning establishment registration and listing for manufacturers of human cellular and tissue-based products that was published in the Federal Register of May 14, 1998 (63 FR 26744). FDA is taking this action in response to a request for an extension and to allow interested parties additional time for review and to submit comments.
D017690:Cell Transplantation / Q000592:standards*; D003140:Communicable Disease Control; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D006801:Humans; D007221:Industry / Q000331:legislation & jurisprudence* / Q000592:standards; D011786:Quality Control; D014183:Transplantation, Heterologous / Q000592:standards*; D014184:Transplantation, Homologous / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration